MEDICUS PHARMA LTD. Increase (Decrease) in Prepaid Expense
MEDICUS PHARMA LTD. (MDCX) reported Increase (Decrease) in Prepaid Expense of $707.32 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-12
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $876.67K, a 271.72% increase year-over-year.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$169.35K.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$35.30K, a 103.28% decline year-over-year.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was -$430.72K, a 723.36% decline year-over-year.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for fiscal 2025 was -$352.82K, a 133.92% decline from fiscal 2024.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for fiscal 2024 was $1.04M, a 555.41% increase from fiscal 2023.
- MEDICUS PHARMA LTD. increase (decrease) in prepaid expense for fiscal 2023 was $158.72K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $876.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $707.32K 10-Q · filed 2026-08-12 | $672.01K derived: sum of 3 quarters · filed 2026-08-12 | $241.29K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$169.35K 10-Q · filed 2026-05-14 | -$204.65K derived: sum of 2 quarters · filed 2026-05-14 | -$635.38K derived: sum of 3 quarters · filed 2026-05-14 | -$399.54K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$35.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$466.03K derived: sum of 2 quarters · filed 2026-03-25 | -$230.19K derived: sum of 3 quarters · filed 2026-08-12 | -$352.82K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$430.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$194.88K derived: sum of 2 quarters · filed 2026-08-12 | -$317.52K 10-Q · filed 2025-11-14 | $760.10K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $235.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $113.20K 10-Q · filed 2026-08-12 | $1.19M derived: sum of 3 quarters · filed 2026-08-12 | $1.26M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$122.64K 10-Q · filed 2026-05-14 | $954.98K derived: sum of 2 quarters · filed 2026-05-14 | $1.02M derived: sum of 3 quarters · filed 2026-05-14 | $979.27K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.15M derived: sum of 2 quarters · filed 2026-03-25 | $1.10M derived: sum of 3 quarters · filed 2026-03-25 | $1.04M 10-K · filed 2026-03-25 |
| 2024-09-30 | $69.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $24.29K derived: sum of 2 quarters · filed 2025-11-14 | -$37.36K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$44.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$106.45K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$61.64K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $158.72K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |